Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_assertion type Assertion NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_head.
- NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_assertion description "[These results suggest that systemic delivery and sustained production of endostatin and soluble VEGFR2 can slow intracranial glial tumor growth by both reducing cell proliferation and increasing tumor apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_provenance.
- NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_assertion evidence source_evidence_literature NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_provenance.
- NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_assertion SIO_000772 18447716 NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_provenance.
- NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_assertion wasDerivedFrom befree-2016 NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_provenance.
- NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_assertion wasGeneratedBy ECO_0000203 NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_provenance.